GS-9973

Entospletinib (GS-9973)

6-(1H-吲唑-6-基)-N-[4-(4-吗啉基)苯基]咪唑并[1,2-A]吡嗪-8-胺;GS-9973;GS 9973 ;CS-1602;脾脏酪氨酸激酶(SYK)抑制剂

AKT inhibitor VIII (AKTI-1/2)

1,3-二氢-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮

1,3-二氢-1-[1-[[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基]甲基]-4-哌啶基]-2H-苯并咪唑-2-酮;1-(1-(4-(6-苯基-1H-咪唑并[4,5-G]喹噁啉-7-基)苄基)哌啶-4-基)-1H-苯并[D]咪唑-2(3H)-酮;1,3-二氢-1-[1-[4-(6-苯基-1H-咪唑并[4,5-G]喹喔啉-7-基)苯基甲基]-4-哌啶基]-2H-苯并咪唑-2-酮(AKT抑制剂VIII);AKT抑制剂VIII

JZL195

JZL-195

JZL-195;JZL 195;JZL195;CS-1586

Ipragliflozin

(1S)-1,5-脱水-1-C-[3-[(1-苯并噻吩-2-基)甲基]-4-氟苯基]-D-葡糖醇

伊格列净标准品002;伊格列净/依格列净;(1S)-1,5-脱水-1-{3-[(1-苯并噻吩-2-基)甲基]-4-氟苯基}-D-葡萄糖醇;伊格列净杂质对照品;伊格列净-D3;以格列净L-脯氨酸盐;伊格列净单体 微粉;CS-1580

Gemcitabine elaidate

吉西他滨反油酸酯

CO-101;CO101;CO 101;CP-4126;CP4126;CP 4126;GEMCITABINE ELAIDATE;CO-101;CP-4126;GEMCITABINE 5'-ELAIDATE;CS-1569;吉西他滨反油酸酯

BF 2649

1-[3-[3-(4-氯丙基)丙氧基]丙基]-哌啶盐酸盐

CIPROXIDINE;BF 2649;BF2649;BF-2649;1-[3-[3-(4-氯丙基)丙氧基]丙基]-哌啶盐酸盐;CS-2751;1-[3-[3-(4-氯苯基)丙氧基]丙基]哌啶盐酸盐;PITOLISANT;CIPROXIDINE BF2649;替洛利生盐酸盐;CS-1548;PITOLISANT HYDROCHLORIDE;BF 2649;BF2649;BF-2649

Daprodustat

GSK1278863

GSK1278863,daprodustat;GSK 1278863 NEW;daprodustat,GSK1278863;GSK1278863;Daprodustat;2-(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carboxamido)acetic acid;2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid;(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carbonyl)glycine

AZ7371

N-(2-羟基乙基)-1-[(6-甲氧基-5-甲基嘧啶-4-基)甲基]-6-甲基-1H-吡咯并[3,2-B]吡啶-3-甲酰胺

CS-1538;N-(2-羟基乙基)-1-[(6-甲氧基-5-甲基嘧啶-4-基)甲基]-6-甲基-1H-吡咯并[3,2-B]吡啶-3-甲酰胺;AZ7371;AZ 7371

IDO-IN-1

4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒

4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒;IDO-IN-1抑制剂;CS-1532

JNJ 1661010

N/A

CS-1527;TAKEDA-25;JNJ-1661010;JNJ 1661010

Caspase-9 Inhibitor I

CS-1506

Z-LE(OME)HD(OME)-FMK;Z-LEU-GLU(OME)-HIS-ASP(OME)-FMK;Z-LEU-GLU(OME)-HIS-ASP(OME)-FLUOROMETHYLKETONE;CS-1506

Caspase-3 Inhibitor II

Z-ASP(OME)-GLU(OME)-VAL-ASP(OME)-FMK

N-苄氧羰基-L-ALPHA-天冬氨酰-L-ALPHA-谷氨酰-N-[(1S)-3-氟-1-(2-甲氧基-2-氧代乙基)-2-氧代丙基]-L-缬氨酰胺 1,2-二甲酯;Z-DEVD-FMK;CASPASE-3抑制剂

BV-6

BV 6

CHEBI:47924;BV-6 BV 6;BV-6;BV6;CS-1501;CS-2877

Sotrastaurin (AEB071)

3-(1H-吲哚-3-基)-4-[2-(4-甲基哌嗪-1-基)喹唑啉-4-基]吡咯-2,5-二酮

CS-1479;3-(1H-吲哚-3-基)-4-[2-(4-甲基哌嗪-1-基)喹唑啉-4-基]吡咯-2,5-二酮;AEB071;AEB 071;AEB-071;索曲妥林

LDN193189 Hydrochloride

LDN-193189 HCl

4-(6-(4-(哌嗪-1-基)苯基)吡唑并[1,5-A]嘧啶-3-基)喹啉盐酸盐;CS-1451;4-[6-[4-(1-哌嗪基)苯基]吡唑并[1,5-A]嘧啶-3-基]喹啉盐酸盐;4-(6-(4-(哌嗪-1-基)苯基)吡唑并[1,5-A]嘧;LDN193189 盐酸盐,一种选择性的 BMP I 型受体激酶抑制剂;LDN-193189 HCL;LDN 193189 HCL

JIB-04

5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亚甲基)腙

5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亚甲基)腙>97%;CS-1447;NSC693627;JIB04;JIB 04;NSC-693627;JIB-04;JIB04;5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亚甲基)腙;(E)-5-CHLORO-2-(2-(PHENYL(PYRIDIN-2-YL)METHYLENE)HYDRAZINYL)PYRIDINE

Des(benzylpyridyl) Atazanavir

DES(BENZYLPYRIDYL) ATAZANAVIR

(3S,8S,9S,12S)-3,12-二叔丁基-8-羟基-4,11-二氧代-9-(苯基甲基)-2,5,6,10,13-五氮杂十四烷二酸二甲酯;CS-1428;FT-0665859

BMY 7378

BMY7378抑制剂

BMY7378;BMY-7378;CS-1419;BMY7378抑制剂;BMY 7378 DIHYDROCHLORIDE;8-(2-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL)-8-AZASPIRO(4,5)DECANE-7,9-DIONE DIHYDROCHLORIDE;8-[2-[4-(甲氧基苯基)-1-哌嗪]乙基]-8-氮杂螺[4.5]癸烷-7,9-二酮双盐酸盐;BMY 7378 DIHYDROCHLORIDE;BMY 7378;8-[2-[4-(2-甲氧基苯基)-1-哌嗪基]乙基]-8-氮杂螺[4.5]癸烷-7,9-二酮盐酸盐

S-Ruxolitinib (INCB018424)

环丙基[4-[3-(1H-咪唑-5-基)丙氧基]苯

(3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (ent-Ruxolitinib);(S)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;S-Ruxolitinib (INCB018424);Ruxolitinib (S enantioMer);(3S)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl]propanenitrile;Ruxolitinib Impurity A;Ruxolitinib Impurity 1（(S)-Ruxolitinib）;S-Ruxolitinib

UNC2250

反式-4-[[2-(丁基氨基)-5-[5-(4-吗啉基甲基)-2-吡啶基]-4-嘧啶基]氨基]环己醇

反式-4-[[2-(丁基氨基)-5-[5-(4-吗啉基甲基)-2-吡啶基]-4-嘧啶基]氨基]环己醇;CS-1346